TipRanks
Azenta (CH:BA3)
:BA3
Switzerland Market
BA3
Azenta
RESEARCH TOOLSreports

Azenta (BA3) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

BA3 Analyst Ratings

Moderate Buy
3Ratings
Moderate Buy
2 Buy
1 Hold
0 Sell
Based on 3 analysts giving stock ratings to
Azenta
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BA3 Stock 12 Month Forecast

Average Price Target

―
Based on 3 Wall Street analysts offering 12 month price targets for Azenta in the last 3 months. The average price target is CHF28.89 with a high forecast of CHF30.54 and a low forecast of CHF27.24. The average price target represents a ― change from the last price of ―.
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
Highest Price TargetCHF30.54Average Price TargetCHF28.89Lowest Price TargetCHF27.24
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Needham Analyst forecast on CH:BA3
David Saxon
Needham
Needham
CHF30.54
Buy
―
Reiterated
09/14/26
Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (NASDAQ: SMMT) and Azenta (NASDAQ: AZTA)
Evercore ISI Analyst forecast on CH:BA3
Vijay Kumar
Evercore ISI
Evercore ISI
CHF23.11→CHF28.89
Buy
―
Reiterated
08/06/26
Azenta price target raised to $35 from $28 at Evercore ISIAzenta price target raised to $35 from $28 at Evercore ISI
TD Cowen Analyst forecast on CH:BA3
Brendan Smith
TD Cowen
TD Cowen
CHF16.51→CHF27.24
Hold
―
Reiterated
08/05/26
Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (NASDAQ: CMPS), Geron (NASDAQ: GERN) and Azenta (NASDAQ: AZTA)
Jefferies Analyst forecast on CH:BA3
Matthew Stanton, CFA
Jefferies
Jefferies
CHF33.02→CHF28.89
Buy
―
Reiterated
04/01/26
Azenta price target lowered to $35 from $40 at JefferiesAzenta price target lowered to $35 from $40 at Jefferies
Raymond James Analyst forecast on CH:BA3
Andrew Cooper
Raymond James
Raymond James
CHF28.89→CHF37.15
Buy
―
Reiterated
11/25/25
Azenta price target raised to $45 from $35 at Raymond JamesAzenta price target raised to $45 from $35 at Raymond James
Nephron Analyst forecast on CH:BA3
Thomas DeBourcy
Nephron
Nephron
CHF25.59
Hold
―
Upgraded
11/24/25
Azenta upgraded to Hold from Sell at Nephron ResearchAzenta upgraded to Hold from Sell at Nephron Research
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Needham Analyst forecast on CH:BA3
David Saxon
Needham
Needham
CHF30.54
Buy
―
Reiterated
09/14/26
Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (NASDAQ: SMMT) and Azenta (NASDAQ: AZTA)
Evercore ISI Analyst forecast on CH:BA3
Vijay Kumar
Evercore ISI
Evercore ISI
CHF23.11→CHF28.89
Buy
―
Reiterated
08/06/26
Azenta price target raised to $35 from $28 at Evercore ISIAzenta price target raised to $35 from $28 at Evercore ISI
TD Cowen Analyst forecast on CH:BA3
Brendan Smith
TD Cowen
TD Cowen
CHF16.51→CHF27.24
Hold
―
Reiterated
08/05/26
Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (NASDAQ: CMPS), Geron (NASDAQ: GERN) and Azenta (NASDAQ: AZTA)
Jefferies Analyst forecast on CH:BA3
Matthew Stanton, CFA
Jefferies
Jefferies
CHF33.02→CHF28.89
Buy
―
Reiterated
04/01/26
Azenta price target lowered to $35 from $40 at JefferiesAzenta price target lowered to $35 from $40 at Jefferies
Raymond James Analyst forecast on CH:BA3
Andrew Cooper
Raymond James
Raymond James
CHF28.89→CHF37.15
Buy
―
Reiterated
11/25/25
Azenta price target raised to $45 from $35 at Raymond JamesAzenta price target raised to $45 from $35 at Raymond James
Nephron Analyst forecast on CH:BA3
Thomas DeBourcy
Nephron
Nephron
CHF25.59
Hold
―
Upgraded
11/24/25
Azenta upgraded to Hold from Sell at Nephron ResearchAzenta upgraded to Hold from Sell at Nephron Research
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
LGNDLigand Pharma
DNLIDenali Therapeutics
ACHVAchieve Life Sciences
PMNProMIS Neurosciences
CELCCelcuity
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Azenta

3 Months
David SaxonNeedham
Success Rate
12/33 ratings generated profit
36%
Average Return
-5.58%
Copying David Saxon's trades and holding each position for 3 Months would result in 36.36% of your transactions generating a profit, with an average return of -5.58% per trade.
1 Year
David SaxonNeedham
Success Rate
9/33 ratings generated profit
27%
Average Return
-14.36%
Copying David Saxon's trades and holding each position for 1 Year would result in 27.27% of your transactions generating a profit, with an average return of -14.36% per trade.
2 Years
David SaxonNeedham
Success Rate
8/33 ratings generated profit
24%
Average Return
-21.56%
Copying David Saxon's trades and holding each position for 2 Years would result in 24.24% of your transactions generating a profit, with an average return of -21.56% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BA3 Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
4
3
1
0
0
Buy
0
0
0
2
3
Hold
1
1
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
4
2
3
4
In the current month, BA3 has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. BA3 average Analyst price target in the past 3 months is 28.89.
Each month's total comprises the sum of three months' worth of ratings.

BA3 Financial Forecast

BA3 Earnings Forecast

Next quarter’s earnings estimate for BA3 is CHF0.12 with a range of CHF0.04 to CHF0.17. The previous quarter’s EPS was CHF0.13. BA3 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year BA3 has Performed in-line its overall industry.
Next quarter’s earnings estimate for BA3 is CHF0.12 with a range of CHF0.04 to CHF0.17. The previous quarter’s EPS was CHF0.13. BA3 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year BA3 has Performed in-line its overall industry.

BA3 Sales Forecast

Next quarter’s sales forecast for BA3 is CHF131.17M with a range of CHF129.52M to CHF132.14M. The previous quarter’s sales results were CHF131.88M. BA3 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year BA3 has Performed in-line its overall industry.
Next quarter’s sales forecast for BA3 is CHF131.17M with a range of CHF129.52M to CHF132.14M. The previous quarter’s sales results were CHF131.88M. BA3 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year BA3 has Performed in-line its overall industry.

BA3 Stock Forecast FAQ

What is CH:BA3’s average 12-month price target, according to analysts?
Based on analyst ratings, Azenta’s 12-month average price target is 28.89.
    What is CH:BA3’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:BA3, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Azenta a Buy, Sell or Hold?
        Azenta has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 1 hold ratings and 0 sell ratings.
          What is Azenta’s share price target?
          The average share price target for Azenta is 28.89. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF30.54 ,and the lowest forecast is CHF27.24. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Azenta?
            Azenta’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
              How can I buy shares of Azenta?
              To buy shares of CH:BA3, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.